Our Drug Discovery Alliance is now working on 26 projects exploring potential new dementia treatments – several of which have progressed to the next stage. The Alliance unites academic researchers and dedicated drug discovery scientists at the Universities of Cambridge and Oxford, and University College London.

Find out more about the Chief Scientific Officers of our Institutes in London and Oxford, and what makes them tick.

See more achievements.